Delivery Order SPE2DB20D3101-SPE2DB24FQWG2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.40 firm-fixed-price contract is for the delivery of Plaquenil 200 mg tablets. The contract has a completion date of March 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets in 100-count packages. The contract has a firm fixed price and a ceiling value of $33,529.91. It was awarded on January 15, 2025, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The $29,052.96 contract has a firm fixed price and an ultimate completion date of September 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, that enable efficient procurement of pharmaceutical and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a total ceiling value of $5,330.16 and a period of performance through November 27, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a ceiling value of $1,272.96 and a period of performance through August 8, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, with a ceiling value of $16,165.52 and a period of performance ending on January 27, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.49 to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets in quantities of 100 units. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, operates under firm fixed pricing with no set-aside designation, indicating open and competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Plaquenil 200 mg tablets in 100-count bottles, with a total ceiling value of $1,247.74 and a completion date of December 16, 2022. This contract is not designated as a set-aside and was awarded on December 15, 2022, as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,479.67, is for the supply of Plaquenil 200 mg tablets. Amerisourcebergen is the prime contractor, and there is no mention of any subcontractors. The contract is a firm fixed-price delivery order with a completion date of January 26, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a larger...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQWG2Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,222.18, is for the delivery of Plaquenil 200 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of December 7, 2023. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/6/23 |